Antimicrobial resistance companies develop diagnostics, therapeutics and technologies to address infections that no longer respond effectively to existing medicines. Their work supports faster pathogen identification, improved treatment decisions and the development of new approaches to infection control.
This category includes companies working on:
Browse 57 UK antimicrobial resistance companies below.
Clinical-stage antifungal drug developer targeting invasive fungal infections
F2G is a clinical-stage biopharmaceutical company developing novel antifungal therapies for life-threatening invasive fungal infections. The company discovered the orotomides, a…
High-sensitivity lateral flow diagnostics for point-of-care testing
SwiftDx is a Cambridge-based diagnostics company developing a next generation of high-sensitivity lateral flow assays using proprietary eAMP (enhanced Amplification) and DNA…
Electrochemical lateral flow diagnostics for accessible at-home health testing
éclateral is a UK-based developer of electrochemical lateral flow diagnostic technology for at-home and point-of-care testing. The company's portable reader pairs with adapted…
Polymer-embedded antimicrobial technology for infection prevention in medical devices
Zonova is a biotech company developing patented antimicrobial technology embedded into medical device polymers at the manufacturing stage. The technology creates a protective…
Multiplex qPCR and NGS kits for molecular detection
YouSeq is a UK manufacturer of multiplex Next Generation Sequencing and qPCR kits, panels and reagents. The company offers one of the largest menus of qPCR targets available,…
Enzymatic wound debridement therapy derived from maggot biology
SolasCure is a biotechnology company developing a recombinant enzyme-based hydrogel for the treatment of chronic wounds. The lead product contains a protease cloned from medical…
AI-powered microbiome and phage therapy platform for gut disorders
GutSee Health is a biotechnology company developing precision microbiome therapies for gut disorders including irritable bowel syndrome and inflammatory bowel disease. Its AI…
Infectious disease drug development and partnering organisation
Infex Therapeutics is a clinical-stage drug development company focused on antimicrobial resistance and pandemic-priority infectious diseases, based at Alderley Park. Founded as…
Non-invasive deep lung breath sampling device for molecular research
PulmoBioMed is a medical technology company developing a handheld device for collecting exhaled breath condensate from the lower respiratory tract without contamination from the…
Bacterial-like particle vaccine platform targeting recurrent UTIs
Spectre Bio is a biotechnology company developing a non-antibiotic prophylactic vaccine for recurrent UTIs, a major unmet medical need and significant driver of antimicrobial…
Digital microscope platform for veterinary parasite diagnostics
Techion (UK) is the UK subsidiary of New Zealand-founded Techion Group, developer of an integrated digital diagnostics platform for parasite management in production animals. Its…
Bacteriophage-integrated antibacterial textiles for surgical implant infection prevention
Oxford Silk Phage Technologies is a biotechnology company developing antibacterial biomaterials that integrate bacteriophages into silk-based medical textiles, for use in surgical…